Ashish Upadhyay, MBBS

Associate Professor, Medicine

Ashish Upadhyay
72 E. Concord St Evans Building


Dr. Upadhyay is a board-certified nephrologist with academic interests in examining the relationships and mechanisms of cardio-vascular and cerebro-vascular disease risk factors in patients with chronic kidney disease (CKD), and in assessing the hemodialysis care delivery systems for improvement in clinical outcomes. In addition, he has a special focus in medical education, particularly in areas related to improving the in-patient clinical training environment and the application of evidence-based medicine. He has conducted epidemiologic research in the Framingham Heart Study, led the evidence review team for the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on lipid management in CKD, and participated in the evidence review teams for the KDIGO clinical practice guidelines on blood pressure management in CKD and anemia management in CKD. He maintains an active clinical practice in general nephrology, hemodialysis, and peritoneal dialysis, and is an Associate Program Director of Boston Medical Center’s Internal Medicine Residency Training Program. Outside of Boston University, Dr. Upadhyay serves as a voting member of the Association for the Advancement of Medical Instrumentation (AAMI)’s Renal Disease and Detoxification Committee, the primary source of national and international consensus standards for hemodialysis technology and dialysis water sterilization processes.

Other Positions

  • Associate Program Director Internal Medicine Residency Program, Boston University School of Medicine


  • Tribhuvan University, MBBS


  • Published on 3/8/2018

    Toth PP, Dwyer JP, Cannon CP, Colhoun HM, Rader DJ, Upadhyay A, Louie MJ, Koren A, Letierce A, Mandel J, Banach M. Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease. Kidney Int. 2018 Jun; 93(6):1397-1408. PMID: 29526502.

    Read at: PubMed
  • Published on 6/13/2017

    Upadhyay A, Susantitaphong P, Jaber BL. Ultrapure versus standard dialysate: A cost-benefit analysis. Semin Dial. 2017 09; 30(5):398-402. PMID: 28608933.

    Read at: PubMed
  • Published on 3/1/2017

    Chen C, Upadhyay A. Renal denervation for uncontrolled hypertension: critical review of the evidence. Curr Opin Nephrol Hypertens. 2017 Mar; 26(2):114-122. PMID: 27922849.

    Read at: PubMed
  • Published on 1/8/2017

    Upadhyay A, Jaber BL. Reuse and Biocompatibility of Hemodialysis Membranes: Clinically Relevant? Semin Dial. 2017 Mar; 30(2):121-124. PMID: 28066932.

    Read at: PubMed
  • Published on 4/8/2016

    Upadhyay A, Jaber BL. We Use Impure Water to Make Dialysate for Hemodialysis. Semin Dial. 2016 Jul; 29(4):297-9. PMID: 27061684.

    Read at: PubMed
  • Published on 4/1/2016

    Stillman MD, Miller KH, Ziegler CH, Upadhyay A, Mitchell CK. Program Characteristics Influencing Allopathic Students' Residency Selection. J Am Osteopath Assoc. 2016 Apr; 116(4):214-26. PMID: 27018956.

    Read at: PubMed
  • Published on 11/1/2015

    Upadhyay A, Inker LA, Levey AS. Chronic Kidney Disease: Definition, Classification and Approach to Management. Goldsmith D, Section editor. Oxford Textbook of Clinical Nephrology. Oxford University Press. Oxford, UK. 2015; 743-754.

  • Published on 4/1/2015

    Wang K, Upadhyay A. Sugar-sweetened Beverages and Chronic Kidney Disease. US Endocrinology. 2015; 1(11):41-45; DOI: 10.17925/USE.2015.

    Read at: Custom
  • Published on 10/25/2013

    Upadhyay A. Statins in chronic kidney disease: what do meta-analyses tell us? Clin Exp Nephrol. 2014 Apr; 18(2):278-81. PMID: 24158229.

    Read at: PubMed
  • Published on 10/4/2013

    Roseman DA, Hwang SJ, Manders ES, O'Donnell CJ, Upadhyay A, Hoffmann U, Fox CS. Renal artery calcium, cardiovascular risk factors, and indexes of renal function. Am J Cardiol. 2014 Jan 1; 113(1):156-61. PMID: 24210678.

    Read at: PubMed

View 24 more publications: View full profile at BUMC

View all profiles